Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

RxSight, Inc.

NASDAQ: RXST · Industrial Applications and Services · 2 alerts · CIK 1111485

Share price
$5.30Close, Nov 16
Market cap
$222M
Shares outstanding
41.93MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Ophthalmic GoodsSIC 3851

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All RxSight, Inc. filings on SEC EDGAR ↗

4:16 PM ET 10-Q
Financial Results

RxSight Q3 2026 Results: Net Loss of $16.2M, Loss Widens

RxSight, Inc. reported 41,929,222 shares of common stock outstanding as of October 29, 2026. The company anticipates revenue growth through expanded sales territories and increased doctor adoption of its Light Adjustable Lens (LAL) system, while maintaining that current capital is sufficient to fund operations for at least 12 months.

Key figure
Net loss $16.2M
4:06 PM ET 8-K
Financial Results

RxSight Financial Results

RxSight reported Q3 2026 revenue of $24.6 million, a 19% decrease year-over-year, primarily due to competitive pressures. The company highlighted a strengthened commercial leadership team and a $60 million cash infusion from its strategic collaboration with Alcon, ending the quarter with $254.7 million in cash and investments.

Term
3 months

“Since I joined last quarter, the team has moved quickly and accomplished a great deal in a short period of time. We have strengthened our commercial organization and leadership, made progress across key long-term growth initiatives, and taken decisive actions to align our cost structure with our priorities. While there is more work ahead, we remain focused on execution. Based on our progress, I am confident we are positioning our company for long-term success.”

Aziz Mottiwala, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.